Christopher Fox,Steven G. Reed,Susan Baldwin,Thomas Vedvick
申请号:
US14377488
公开号:
US20150017191A1
申请日:
2013.02.07
申请国别(地区):
US
年份:
2015
代理人:
摘要:
Formulations and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed. The formulations generally comprise a TLR4 agonist and a metabolizable oil at a concentration of about 0.01%-1% v/v, wherein the hydrophobic:lipophilic balance (HLB) of the emulsion is greater than about 9.